The Data You’ll Never See is Holding Pharma Back
Here’s the blunt truth: your competitors are already training models on data you can’t touch—because they’ve figured out blinded collaboration: cross-org analysis on encrypted data, with attestation, zero raw sharing, and no IP leakage.
This webinar is the first time you’ll see it run live end-to-end: models, prompts, and sensitive datasets governed inside confidential computing—auditable, defensible, production-ready. Miss it, and your next safety signal, label expansion, or trial acceleration might belong to someone else.
Attend, and you’ll walk away with the blueprint to unlock multi-party evidence without breaking privacy or compliance—plus the exact rollout steps from pilot to scale. This isn’t another vendor pitch; it’s the operating model that will define the next decade of pharma. If you own outcomes, clear your calendar.
Speakers:
Patrick Conte
Garth Whitacre
Dr. Richard Searle
Register Now
Here’s the blunt truth: your competitors are already training models on data you can’t touch—because they’ve figured out blinded collaboration: cross-org analysis on encrypted data, with attestation, zero raw sharing, and no IP leakage.
This webinar is the first time you’ll see it run live end-to-end: models, prompts, and sensitive datasets governed inside confidential computing—auditable, defensible, production-ready. Miss it, and your next safety signal, label expansion, or trial acceleration might belong to someone else.
Attend, and you’ll walk away with the blueprint to unlock multi-party evidence without breaking privacy or compliance—plus the exact rollout steps from pilot to scale. This isn’t another vendor pitch; it’s the operating model that will define the next decade of pharma. If you own outcomes, clear your calendar.
Speakers:
Patrick Conte
Garth Whitacre
